{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:38:17Z","timestamp":1786628297164,"version":"build-2736575974"},"reference-count":92,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Postherpetic neuralgia (PHN) is a common, painful, and long-term complication of herpes zoster (HZ). PHN increases the demand for healthcare services and, previous studies showed that patients who received antiviral agents were less likely to develop PHN. The objective of this study was to compare the efficacy of prodrugs and acyclovir in treating PHN among patients with HZ. The search included the PubMed, Medline, Embase, and Cochrane Center of Register of Controlled Trails databases through February 2022. Clinical trials and randomized controlled trials (RCTs) involving antiviral agent intervention for HZ patients diagnosed with PHN were eligible for inclusion. A meta-analysis was conducted to calculate pooled risk ratios (RRs) with 95% confidence intervals (CIs) with a fix-effect model. Five RCTs with 1147 HZ patients met our eligibility criteria. Our meta-analysis found that there was a significantly lower risk of PHN for members of the prodrugs group (famciclovir and valaciclovir) compared with those who received acyclovir (RR = 0.86, 95%, CI: 0.75 to 0.98, p = 0.03). The review of studies indicated that the efficacy of prodrugs was better than acyclovir for reliving PHN.<\/jats:p>","DOI":"10.3390\/healthcare10071181","type":"journal-article","created":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T09:00:13Z","timestamp":1656234013000},"page":"1181","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Comparing Prodrugs with Acyclovir for Treating Postherpetic Neuralgia among Herpes Zoster Patients: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"10","author":[{"given":"Chung-Hsin","family":"Yeh","sequence":"first","affiliation":[{"name":"Department of Neurology, Yuan Rung Hospital, Changhua 510005, Taiwan"},{"name":"Department of Nursing, College of Nursing and Health, Da-Yeh University, Changhua 515006, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko-Shih","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yuan Rung Hospital, Changhua 510005, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Shiung","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Nursing, College of Nursing and Health, Da-Yeh University, Changhua 515006, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3419-9110","authenticated-orcid":false,"given":"Shiow-Luan","family":"Tsay","sequence":"additional","affiliation":[{"name":"Department of Nursing, College of Nursing and Health, Da-Yeh University, Changhua 515006, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Mei","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Nursing, College of Nursing and Health, Da-Yeh University, Changhua 515006, Taiwan"},{"name":"Department of Nursing, Mackay Memorial Hospital, Taipei 25160, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Jung","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nursing, College of Nursing and Health, Da-Yeh University, Changhua 515006, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.idc.2017.07.016","article-title":"Herpes Zoster in the Older Adult","volume":"31","author":"John","year":"2017","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_2","first-page":"656","article-title":"Herpes Zoster and Postherpetic Neuralgia: Prevention and Management","volume":"96","author":"Saguil","year":"2017","journal-title":"Am. Fam. Physician"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1080\/21645515.2020.1847582","article-title":"A systematic literature review of herpes zoster incidence worldwide","volume":"17","author":"Vroling","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_4","unstructured":"Centers for Disease Control and Prevention (2021, December 10). Shingles (Herpes Zoster), Available online: https:\/\/www.cdc.gov\/shingles\/hcp\/clinical-overview.html."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/cid\/ciy953","article-title":"The Epidemiology of Herpes Zoster in the United States During the Era of Varicella and Herpes Zoster Vaccines: Changing Patterns Among Older Adults","volume":"69","author":"Harpaz","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Marra, F., Chong, M., and Najafzadeh, M. (2016). Increasing incidence associated with herpes zoster infection in British Columbia, Canada. BMC Infect. Dis., 16.","DOI":"10.1186\/s12879-016-1898-z"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.14745\/ccdr.v44i09a06","article-title":"Summary of the NACI Update on Herpes Zoster Vaccines","volume":"44","author":"Warrington","year":"2018","journal-title":"Can. Commun. Dis. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/j.vaccine.2018.02.021","article-title":"Effectiveness of herpes zoster vaccination in an older United Kingdom population","volume":"36","author":"Walker","year":"2018","journal-title":"Vaccine"},{"key":"ref_9","first-page":"71","article-title":"Varicella and herpes zoster incidence prior to the introduction of systematic child vaccination in Navarre, 2005\u20132006","volume":"31","author":"Castilla","year":"2008","journal-title":"Sist. Sanit. Navar."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jinf.2018.02.001","article-title":"Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged \u226550 years: A prospective study","volume":"76","author":"Schutter","year":"2018","journal-title":"J. Infect."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jinf.2020.12.013","article-title":"Incidence and disease burden of herpes zoster in the population aged \u226550 years in China: Data from an integrated health care network","volume":"82","author":"Sun","year":"2021","journal-title":"J. Infect."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1080\/21645515.2019.1603985","article-title":"Trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003\u20132015","volume":"15","author":"Choi","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3346\/jkms.2019.34.e1","article-title":"Recurrence Rate of Herpes Zoster and Its Risk Factors: A Population-based Cohort Study","volume":"34","author":"Kim","year":"2019","journal-title":"J. Korean Med. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"ofx007","DOI":"10.1093\/ofid\/ofx007","article-title":"Herpes Zoster and Recurrent Herpes Zoster","volume":"4","author":"Shiraki","year":"2017","journal-title":"Open Forum Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/jmv.21599","article-title":"Epidemiology of herpes zoster and its relationship to varicella in Japan: A 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture","volume":"81","author":"Toyama","year":"2009","journal-title":"J. Med. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12889-018-5247-6","article-title":"Epidemiology and long-term disease burden of herpes zoster and postherpetic neuralgia in Taiwan: A population-based, propensity score-matched cohort study","volume":"18","author":"Lu","year":"2018","journal-title":"BMC Public Health"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4103\/ijdvl.IJDVL_1021_16","article-title":"Epidemiology, treatment and prevention of herpes zoster: A comprehensive review","volume":"84","author":"Koshy","year":"2018","journal-title":"Indian J. Derm. Venereol. Leprol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00105-016-3834-y","article-title":"Herpes zoster and postherpetic neuralgia","volume":"67","author":"Wollina","year":"2016","journal-title":"Hautarzt"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3810\/pgm.2013.09.2703","article-title":"Herpes zoster: Diagnostic, therapeutic, and preventive approaches","volume":"125","author":"Bader","year":"2013","journal-title":"Postgrad. Med."},{"key":"ref_20","first-page":"10","article-title":"Herpes zoster in older adults","volume":"36","author":"Cadogan","year":"2010","journal-title":"Case Rep. J. Gerontol. Nurs."},{"key":"ref_21","unstructured":"National Development Council (2021, July 07). Population Projections for the Republic of China (Taiwan): 2020\u20132070. National Development Council, Available online: https:\/\/pop-proj.ndc.gov.tw\/main_en\/download.aspx?uid=4105&pid=4104."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40122-019-0127-z","article-title":"The Epidemiology of Herpes Zoster and Postherpetic Neuralgia in China: Results from a Cross-Sectional Study","volume":"8","author":"Yang","year":"2019","journal-title":"Pain Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002512-200724010-00001","article-title":"Post-herpetic neuralgia in older adults: Evidence-based approaches to clinical management","volume":"24","author":"Christo","year":"2007","journal-title":"Rev. Drugs Aging"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0885-3924(02)00393-7","article-title":"Clinical applications for change-point analysis of herpes zoster pain","volume":"23","author":"Desmond","year":"2002","journal-title":"J. Pain Symptom. Manag."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/S0140-6736(94)93106-2","article-title":"Proposed classification of herpes zoster pain","volume":"343","author":"Dworkin","year":"1994","journal-title":"Lancet"},{"key":"ref_26","first-page":"861","article-title":"Post-herpetic neuralgia","volume":"5","author":"Tontodonati","year":"2012","journal-title":"Int. J. Gen. Med."},{"key":"ref_27","unstructured":"Nair, P.A., and Patel, B.C. (2021). Herpes Zoster. StatPearls, StatPearls Publishing LLC."},{"key":"ref_28","first-page":"1432","article-title":"Herpes zoster and postherpetic neuralgia: Prevention and management","volume":"83","author":"Fashner","year":"2011","journal-title":"Am. Fam. Physician"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3344\/kjp.2018.31.4.235","article-title":"Modalities in managing postherpetic neuralgia","volume":"31","author":"Shrestha","year":"2018","journal-title":"Korean J. Pain"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Friesen, K.J., Chateau, D., Falk, J., Alessi-Severini, S., and Bugden, S. (2017). Cost of shingles: Population based burden of disease analysis of herpes zoster and postherpetic neuralgia. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2185-3"},{"key":"ref_31","first-page":"1","article-title":"Prevention of herpes zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Practice Guideline","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: Towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"ref_33","first-page":"263","article-title":"Clinical Study of Spinal Cord Stimulation and Pulsed Radiofrequency for Management of Herpes Zoster-Related Pain Persisting Beyond Acute Phase in Elderly Patients","volume":"23","author":"Liu","year":"2020","journal-title":"Pain Physician"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.bbmt.2009.03.003","article-title":"Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group","volume":"15","author":"Onozawa","year":"2009","journal-title":"Multicent. Study Biol. Blood Marrow Transpl."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/jmv.24750","article-title":"FV-100 versus valacyclovir for the prevention of post-herpetic neuralgia and the treatment of acute herpes zoster-associated pain: A randomized-controlled trial","volume":"89","author":"Tyring","year":"2017","journal-title":"J. Med. Virol."},{"key":"ref_36","first-page":"84","article-title":"Neuropathic pain of postherpetic neuralgia","volume":"85","author":"Gharibo","year":"2011","journal-title":"Pain Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(99)01307-0","article-title":"Neuropathic pain: Aetiology, symptoms, mechanisms, and management","volume":"353","author":"Woolf","year":"1999","journal-title":"Lancet"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1631\/jzus.B0920049","article-title":"Influence of systemic immune and cytokine responses during the acute phase of zoster on the development of postherpetic neuralgia","volume":"10","author":"Zhu","year":"2009","journal-title":"J. Zhejiang Univ Sci. B"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1113-e88","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1212\/01.WNL.0000140708.62856.72","article-title":"Practice parameter: Treatment of postherpetic neuralgia: An evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"63","author":"Dubinsky","year":"2004","journal-title":"Neurology"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Hempenstall, K., Nurmikko, T.J., Johnson, R.W., A\u2019Hern, R.P., and Rice, A.S. (2005). Analgesic therapy in postherpetic neuralgia: A quantitative systematic review. PLoS Med., 2.","DOI":"10.1371\/journal.pmed.0020164"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/1346-8138.13948","article-title":"Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: A randomized, double-blind, valaciclovir-controlled phase 3 study","volume":"44","author":"Kawashima","year":"2017","journal-title":"J. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"ref_44","first-page":"25151355221084535","article-title":"Global herpes zoster incidence, burden of disease, and vaccine availability: A narrative review","volume":"10","author":"Pan","year":"2022","journal-title":"Adv. Vaccines Immunother."},{"key":"ref_45","first-page":"Cd006866","article-title":"Antiviral treatment for preventing postherpetic neuralgia","volume":"2","author":"Li","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1086\/522159","article-title":"Vaccination against Herpes Zoster and Postherpetic Neuralgia","volume":"197","author":"Oxman","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/10489140-000000000-00000","article-title":"Zoster vaccine (Zostavax): A review of its use in preventing herpes zoster and postherpetic neuralgia in older adults","volume":"27","author":"Sanford","year":"2010","journal-title":"Drugs Aging"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/jac\/dkm376","article-title":"Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus","volume":"60","author":"McGuigan","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1086\/514011","article-title":"Evaluation of sorivudine (BV-araU) versus acyclovir in the treatment of acute localized herpes zoster in human immunodeficiency virus-infected adults","volume":"176","author":"Bodsworth","year":"1997","journal-title":"J. Infect. Dis."},{"key":"ref_51","unstructured":"Stankus, S.J., Dlugopolski, M., and Packer, D. (2000). Management of herpes zoster (shingles) and postherpetic neuralgia. Am. Fam. Physician, 61."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1128\/AAC.39.7.1546","article-title":"Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults","volume":"39","author":"Beutner","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_53","first-page":"84","article-title":"Therapy of herpes zoster with oral acyclovir","volume":"85","author":"Huff","year":"1988","journal-title":"Am. J. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1386-6532(03)00164-1","article-title":"Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: A randomized, multicenter, double-blind clinical trial","volume":"29","author":"Shafran","year":"2004","journal-title":"J. Clin. Virol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s40257-013-0011-2","article-title":"Management of Herpes Zoster and Post-Herpetic Neuralgia","volume":"14","author":"Gan","year":"2013","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.medmal.2011.11.001","article-title":"Effectiveness of antiviral treatment on acute phase of herpes zoster and development of post herpetic neuralgia: Review of international publications","volume":"42","author":"Bruxelle","year":"2012","journal-title":"Med. Et Mal. Infect."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1517\/13543784.6.2.173","article-title":"Valaciclovir: Development, clinical utility and potential","volume":"6","author":"Patel","year":"1997","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_58","first-page":"75","article-title":"Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster","volume":"37","author":"Shen","year":"2004","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1081\/CNV-100000070","article-title":"A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients","volume":"19","author":"Tyring","year":"2001","journal-title":"Cancer Investig."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2165\/00002512-200320080-00002","article-title":"The role of antivirals in the management of neuropathic pain in the older patient with herpes zoster","volume":"20","author":"Lilie","year":"2003","journal-title":"Drugs Aging"},{"key":"ref_61","first-page":"208","article-title":"Role of acyclovir and laser therapy in herpes zoster. Article","volume":"60","author":"Chopra","year":"1994","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_62","first-page":"269","article-title":"Factors affecting therapeutic compliance: A review from the patient's perspective","volume":"4","author":"Jin","year":"2008","journal-title":"Clin. Risk Manag."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-123-2-199507150-00002","article-title":"Famciclovir for the treatment of acute herpes zoster: Effects on acute disease and postherpetic neuralgia: A randomized, double-blind, placebo-controlled trial","volume":"123","author":"Tyring","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/jinf.2002.0988","article-title":"The Effect of Vaccination on the Epidemiology of Varicella Zoster Virus","volume":"44","author":"Edmunds","year":"2002","journal-title":"J. Infect."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/archfami.9.9.863","article-title":"Antiviral therapy for herpes zoster: Randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older","volume":"9","author":"Tyring","year":"2000","journal-title":"Arch. Fam. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/clinids\/22.2.341","article-title":"Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: A meta-analysis of placebo-controlled trials","volume":"22","author":"Wood","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"ref_67","first-page":"93","article-title":"Oral acyclovir in the treatment of herpes zoster in general practice","volume":"102","author":"Morton","year":"1989","journal-title":"N. Z. Med. J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archinte.1997.00440290095010","article-title":"The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia","volume":"157","author":"Jackson","year":"1997","journal-title":"Arch. Intern. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/bmj.309.6962.1124","article-title":"Acyclovir and post-herpetic neuralgia and ocular involvement","volume":"309","author":"McGill","year":"1994","journal-title":"BMJ"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s15010-013-0550-8","article-title":"Incidence of herpes zoster in patients with altered immune function","volume":"42","author":"Chen","year":"2014","journal-title":"Infection"},{"key":"ref_71","first-page":"443","article-title":"Retrospective investigation of postherpetic neuralgia","volume":"69","author":"Haas","year":"1994","journal-title":"H + G: Z. F\u00fcr Hautkrankh."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1136\/bmj.310.6985.1005a","article-title":"Acyclovir and post-herpetic neuralgia. The balance of available evidence supports its use","volume":"310","author":"Harding","year":"1995","journal-title":"BMJ"},{"key":"ref_73","first-page":"121","article-title":"Treatment of postherpetic neuralgia: A systematic review of the literature","volume":"51","author":"Alper","year":"2002","journal-title":"J. Fam. Pract."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1600-0781.2006.00236.x","article-title":"Broad-band ultraviolet B phototherapy in zoster patients may reduce the incidence and severity of postherpetic neuralgia","volume":"22","author":"Ansarin","year":"2006","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_76","first-page":"397","article-title":"Subcutaneous injection of triamcinolone and lidocaine to prevent postherpetic neuralgia","volume":"20","author":"Ni","year":"2017","journal-title":"Pain Physician"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3855\/jidc.849","article-title":"The efficacy of time-based short-course acyclovir therapy in treatment of post-herpetic pain","volume":"4","author":"Rasi","year":"2010","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0033-3182(90)72166-4","article-title":"A double-blind, placebo-controlled study of oral acyclovir in postherpetic neuralgia","volume":"31","author":"Surman","year":"1990","journal-title":"Psychosomatics"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-2133.1987.tb04930.x","article-title":"Oral acyclovir for herpes zoster: A double-blind controlled trial in normal subjects","volume":"117","author":"Wassilew","year":"1987","journal-title":"Br. J. Dermatol."},{"key":"ref_80","first-page":"2904","article-title":"A Comparative study to evaluate the efficacy and safety of acyclovir and famciclovir in the management of herpes zoster","volume":"7","author":"Gopal","year":"2013","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0304-3959(75)90044-5","article-title":"The McGill Pain Questionnaire: Major properties and scoring methods","volume":"1","author":"Melzack","year":"1975","journal-title":"Pain"},{"key":"ref_82","unstructured":"Higgins, J.P.T. (2021). Cochrane Handbook for Systematic Reviews of Interventions, John Wiley & Sons Ltd. [6.2 ed.]."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.bja.2019.08.015","article-title":"Use of the GRADE approach in systematic reviews and guidelines","volume":"123","author":"Granholm","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"ref_84","first-page":"138","article-title":"Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster","volume":"34","author":"Lin","year":"2001","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0924-8579(94)90024-8","article-title":"Famciclovir, a new oral antiherpes drug: Results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients","volume":"4","author":"Degreef","year":"1994","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2165\/00003495-200059060-00009","article-title":"Valaciclovir: A review of its use in the management of herpes zoster","volume":"59","author":"Ormrod","year":"2000","journal-title":"Drugs"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/clpt.1993.196","article-title":"Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers","volume":"54","author":"Weller","year":"1993","journal-title":"Clin. Pharm. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2710.2001.00363.x","article-title":"Patient adherence to treatment: Three decades of research","volume":"26","author":"Vermeire","year":"2001","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/pgmj.73.864.623","article-title":"The management of postherpetic neuralgia","volume":"73","author":"Bowsher","year":"1997","journal-title":"Postgrad. Med. J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e3210","DOI":"10.1093\/cid\/ciaa1185","article-title":"Herpes Zoster and Postherpetic Neuralgia: Changing Incidence Rates From 1994 to 2018 in the United States","volume":"73","author":"Thompson","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1210\/clinem\/dgab675","article-title":"Association Between Diabetes Mellitus and the Risk of Herpes Zoster: A Systematic Review and Meta-analysis","volume":"107","author":"Huang","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"ofu049","DOI":"10.1093\/ofid\/ofu049","article-title":"Incidence of herpes zoster and persistent post-zoster pain in adults with or without diabetes in the United States","volume":"1","author":"Suaya","year":"2014","journal-title":"Open Forum Infect. Dis."}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/10\/7\/1181\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:39:17Z","timestamp":1760139557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/10\/7\/1181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":92,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["healthcare10071181"],"URL":"https:\/\/doi.org\/10.3390\/healthcare10071181","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]}}}